MaxCyte, Inc. (AIM:MXCT)
London
· Delayed Price · Currency is GBP · Price in GBX 165.00
-3.90 (-2.36%)
Jun 18, 2025, 4:35 PM GMT+1
MaxCyte Market Cap
MaxCyte has a market cap or net worth of 175.59 million as of June 18, 2025. Its market cap has decreased by -52.01% in one year.
Market Cap
175.59M
Enterprise Value
83.14M
Revenue
29.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
165.00
Market Cap Chart
Since March 29, 2016, MaxCyte's market cap has increased from 33.25M to 175.59M, an increase of 428.00%. That is a compound annual growth rate of 19.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| GSK plc | 59.94B |
| Haleon | 34.62B |
| Smith & Nephew | 9.43B |
| ConvaTec Group | 5.85B |
| Hikma Pharmaceuticals | 4.58B |
| HUTCHMED (China) | 2.02B |
| Indivior | 1.28B |